All lobbying filings

SMITHBUCKLIN CORPORATION

Lobbying for ASTCT · Healthcare Society

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $70,000.00 income · posted Jul 17, 2026

Official filing document

Bills named in this filing 8

S 4440
Clinical Trial Modernization Act
HR 3521
Clinical Trial Modernization Act
HR 2491
ABC Act
S 1227
ABC Act
HR 5160
Stem Cell Therapeutic and Research Reauthorization Act of 2025
S 4109
Stem Cell Therapeutic and Research Reauthorization Act of 2026
HR 1262
Mikaela Naylon Give Kids a Chance Act
S 932
Give Kids a Chance Act of 2025

Lobbying activity 3

Medical/Disease Research/Clinical Labs

- Labor-HHS Appropriations - CAR-T Therapy clarification - S. 4440/H.R. 3521, the Clinical Trial Modernization Act

Health Issues

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act

Medicare/Medicaid

- CMS coding and billing clarity for CAR-T therapies - CMS engagement on MS-DRG 018 for CAR-T therapies - H.R. 2491/S. 1227, the Alleviating Barriers to Care Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.